Rosa María
Alonso Rojas
University Medical Center Freiburg
Friburgo de Brisgovia, AlemaniaPublicaciones en colaboración con investigadores/as de University Medical Center Freiburg (8)
2011
-
Development of an LC-MS/MS method for the quantitation of 55 compounds prescribed in combined cardiovascular therapy
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 879, Núm. 3-4, pp. 243-252
2010
-
LC-MS/MS method for the determination of several drugs used in combined cardiovascular therapy in human plasma
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 878, Núm. 28, pp. 2685-2692
2009
-
Optimization and validation of a SPE-HPLC-PDA-fluorescence method for the simultaneous determination of drugs used in combined cardiovascular therapy in human plasma
Journal of Pharmaceutical and Biomedical Analysis, Vol. 50, Núm. 4, pp. 630-639
-
Validation of a fast liquid chromatography-UV method for the analysis of drugs used in combined cardiovascular therapy in human plasma
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 877, Núm. 27, pp. 3045-3053
2007
-
Hydrolysis and transesterification reactions of candesartan cilexetil observed during the solid phase extraction procedure
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 855, Núm. 2 SPEC. ISS., pp. 134-138
-
Validated quantitation of angiotensin II receptor antagonists (ARA-II) in human plasma by liquid-chromatography-tandem mass spectrometry using minimum sample clean-up and investigation of ion suppression
Therapeutic Drug Monitoring, Vol. 29, Núm. 6, pp. 824-834
2006
-
Instability of calcium channel antagonists during sample preparation for LC-MS-MS analysis of serum samples
Forensic Science International, Vol. 156, Núm. 1, pp. 23-34
2005
-
Quantitative determination of the calcium channel antagonists amlodipine, lercanidipine, nitrendipine, felodipine, and lacidipine in human plasma using liquid chromatography-tandem mass spectrometry
Therapeutic Drug Monitoring, Vol. 27, Núm. 1, pp. 44-52